Company intelligence / Profile preview

Al Mokhtabar

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Al Mokhtabar is the largest private medical laboratory network in Egypt and the Middle East, offering over 1,400 types of clinical tests. It is recognized for its CAP accreditation since 2010—the only such lab in Egypt—ensuring international quality standards. The company supports patient care and pharmaceutical programs with advanced diagnostics and has played a key role during public health crises such as COVID‑19.

Therapeutic areas: OncologyCardiovascularDermatologyInfectious Diseases
Modalities: Diagnostic test
Industry: Molecular Diagnostics

Partnerships

Pure Health

Beyond the preview

Go deeper on Al Mokhtabar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Al Mokhtabar.

Explore the full profile